Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
EU Regulation No 2701/1994 · Adopted 7 November 1994 · Extends to United Kingdom
Commission Regulation (EC) No 2701/94
of 7 November 1994
amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
(Text with EEA relevance)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal originf1, as last amended by Commission Regulation (EC) No 1430/94f2, and in particular Articles 6, 7 and 8 thereof,
Whereas, since the adoption of the Regulation, the Annexes have been amended a number of times; whereas, by reason of their number, their complexity and their dispersal among various Official Journals of the European Communities, the texts are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, they should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;
Whereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the adaptation to technical progress of directives on the removal of technical barriers to trade in the veterinary medicinal products sector,
HAS ADOPTED THIS REGULATION:
Annotations to the whole text
Footnotes
Contents
1
Annexes I, II, III and IV to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.
2
This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.
Signature
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 7 November 1994.
For the Commission
Martin Bangemann
Member of the Commission
ANNEX I
List of pharmacologically active substances for which maximum residue limits have been fixed
- 1..
Anti-infectious agents
- 1.1.
Chemotherapeutics
- 1.1.1.
Sulfonamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions All substances belonging to the sulfonamide group Parent drug All food producing species 100 μg/kg Muscle, liver, kidney, fat The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg - 1.2.
Antibiotics
- 1.2.1.
Penicillins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.2.1.1.
Benzylpenicillin
Benzylpenicillin All food producing species 50 μg/kg Muscle, liver, kidney, fat 4 μg/kg Milk 1.2.1.2.
Ampicillin
Ampicillin All food producing species 50 μg/kg Muscle, liver, kidney, fat 4 μg/kg Milk 1.2.1.3.
Amoxicillin
Amoxicillin All food producing species 50 μg/kg Muscle, liver, kidney, fat 4 μg/kg Milk 1.2.1.4.
Oxacillin
Oxacillin All food producing species 300 μg/kg Muscle, liver, kidney, fat 30 μg/kg Milk 1.2.1.5.
Cloxacillin
Cloxacillin All food producing species 300 μg/kg Muscle, liver, kidney, fat 30 μg/kg Milk 1.2.1.6.
Dicloxacillin
Dicloxacillin All food producing species 300 μg/kg Muscle, liver, kidney, fat 30 μg/kg Milk - 1.2.2.
Cephalosporins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.2.2.1.
Cefquinome
Cefquinome Bovine 200 μg/kg Kidney 100 μg/kg Liver 50 μg/kg Muscle 50 μg/kg Fat - 1.2.3.
Quinolones
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.2.3.1.
Enrofloxacin
Sum of enrofloxacin and ciprofloxacin Bovine, porcine, poultry 30 μg/kg Muscle, liver, kidney - 1.2.4.
Macrolides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.2.4.1. Tilmicosin Tilmicosin Bovine 1 000 μg/kg Liver, kidney 50 μg/kg Muscle, fat - 2..
Antiparasitic agents
- 2.1.
Agents acting against endoparasites
- 2.1.1.
Avermectins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 2.1.1.1.
Ivermectin
22,23- Dihydroavermectin B1a Bovine 100 μg/kg Liver 40 μg/kg Fat Porcine 15 μg/kg Liver Ovine 20 μg/kg Fat Equidae 2.1.1.2.
Abamectin
Avermectin B1a Bovine 20 μg/kg Liver 10 μg/kg Fat 2.1.1.3.
Doramectin
Doramectin Bovine 15 μg/kg Liver 25 μg/kg Fat - 2.1.2
Salicylanilides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 2.1.2.1.
Closantel
Closantel Bovine 1 000 μg/kg Muscle, liver 3 000 μg/kg Kidney, fat Ovine 1 500 μg/kg Muscle, liver 5 000 μg/kg Kidney, fat 2 000 μg/kg ANNEX II
List of substances not subject to maximum residue limits
- 1..
Inorganic chemicals
Pharmacologically active substance(s) Animal species Other provisions 1.1.
Hydrogen peroxide
Fish 1.2.
Sulphur
Bovine Porcine Ovine Caprine Equidae 1.3.
Iodine and iodine inorganic compounds including:
Sodium and potassium — iodide
Sodium and potassium — iodate
Iodophors including polyvinylpyrrolidone — iodine
All food producing species 1.4.
Sodium chlorite
Bovine For tropical use only - 2..
Organic compounds
Pharmacologically active substance(s) Animal species Others provisions 2.1.
Etiproston tromethamine
Bovine Porcine 2.2.
Ketanserin tartrate
Equidae 2.3.
Fertirelin acetate
Bovine 2.4.
Human menopausal urinary gonadotrophin
Bovine 2.5.
Lactic acid
All food producing species 2.6.
Melatonin
Ovine Caprine 2.7.
Iodine organic compounds
Iodoform
All food producing species 2.8.
Acetyl cysteine
All food producing species ANNEX III
List of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed
- 1..
Anti-infectious agents
- 1.1.
Chemotherapeutics
- 1.1.1.
Sulfonamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions All substances belonging to the sulfonamide group Parent drug Bovine, ovine, caprine 100 μg/kg Milk Provisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg
- 1.1.2.
Diamino pyrimidine derivates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.1.2.1.
Trimethoprim
Trimethoprim All food producing species 50 μg/kg Muscle, liver, kidney, fat, milk Provisional MRL expires on 1. 1. 1996 - 1.1.3.
Nitrofurans
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.1.3.1.
Furazolidone
All residues with intact 5-nitro structure All food producing species 5 μg/kg Muscle, liver, kidney, fat Provisional MRL expires on 1. 7. 1995 - 1.1.4.
Nitroimidazoles
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.1.4.1.
Dimetridazole
All residues with intact nitroimidazole structure All food producing species 10 μg/kg Muscle, liver, kidney, fat Provisional MRL expires on 1. 1. 1995 - 1.2.
Antibiotics
- 1.2.1.
Tetracyclines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions All substances belonging to the tetracycline group Parent drug All food producing species 600 μg/kg Kidney Provisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated 300 μg/kg Liver 200 μg/kg Eggs 100 μg/kg Muscle 100 μg/kg Milk - 1.2.2.
Macrolides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 1.2.2.1.
Spiramycin
Spiramycin Bovine, porcine 300 μg/kg Liver, Provisional MRLs expire on 1. 7. 1995. The MRLs for liver, kidney and muscle apply to both the bovine and porcine species 200 μg/kg Kidney, 50 μg/kg Muscle Bovine 150 μg/kg Milk 1.2.2.2. Tylosin Bovine 100 μg/kg Muscle, liver, kidney Provisional MRLs expire on 1. 7. 1995 Porcine Poultry Bovine 50 μg/kg Milk - 1.2.3.
Thiamphenicol and related compounds
Pharmacologically active substance(s) Market residue Animal species MRLs Target tissues Other provisions 1.2.3.1.
Thiamphenicol
Thiamphenicol Bovine
Poultry
40 μg/kg Muscle, liver, kidney, fat Provisional MRL expires on 1. 1. 1996 - 2..
Antiparasitic agents
- 2.1.
Agents acting against endo-parasites
- 2.1.1.
Benzimidazoles and pro-benzimidazoles
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 2.1.1.1.
Febantel
Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole All food producing species 1 000 μg/kg Liver Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole 10 μg/kg Muscle, kidney, fat 10 μg/kg Milk 2.1.1.2.
Fenbendazole
Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole All food producing species 1 000 μg/kg Liver Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole 10 μg/kg Muscle, kidney, fat 10 μg/kg Milk 2.1.1.3.
Oxfendazole
Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole All food producing species 1 000 μg/kg Liver Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole
10 μg/kg Muscle, kidney, fat 10 μg/kg Milk 2.1.1.4.
Albendazole
Sum of albendazole and metabolites which are measured as 2-amino-benzimidazole sulphone Bovine 100 μg/kg Muscle, fat, milk, Provisional MRLs expire on 1. 1. 1996 Ovine 500 μg/kg Kidney 1 000 μg/kg Liver 2.1.1.5.
Thiabendazole
Sum of thiabendazole and 5-hydroxythiabendazole Bovine 100 μg/kg Muscle, liver, kidney, fat, milk Provisional MRLs expire on 1. 1. 1996 Ovine Caprine 2.1.1.6.
Triclabendazole
Sum of extractable residues that may be oxidized to ketotriclabendazole Bovine 150 μg/kg Muscle, liver, kidney Provisional MRLs expire on 1. 7. 1995 Ovine 50 μg/kg Fat 2.1.1.7.
Flubendazole
Flubendazole Poultry 500 μg/kg Liver, Provisional MRLs expire on 1. 1. 1996 Game birds 200 μg/kg Muscle, 400 μg/kg Eggs Porcine 10 μg/kg Muscle, liver, kidney, fat 2.1.1.8.
Oxibendazole
Oxibendazole Bovine
Ovine
100 μg/kg Muscle, liver, kidney, fat Provisional MRLs expire on 1. 1. 1996 50 μg/kg Milk Porcine
Equidae
100 μg/kg Muscle, liver, kidney, fat - 2.1.2.
Tetra-hydro-imidazoles (imidazolthiazoles)
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 2.1.2.1.
Levamisole
Levamisole All food producing species 10 μg/kg Musle, liver, kidney, fat, milk Provisional MRL expires on 1. 1. 1995 - 2.2.
Agents acting against ectoparasites
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 2.2.1.
Amitraz
Sum of amitraz and metabolites which are measured as 2,4-dimethylaniline Porcine 50 μg/kg Muscle Provisional MRLs expire on 1. 7. 1996. 200 μg/kg Kidney, liver - 3..
Agents acting on the nervous system
- 3.1.
Agents acting on the central nervous system
- 3.1.1.
Butyrophenone tranquilizers
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 3.1.1.1.
Azaperone
Azaperol All food producing species 100 μg/kg Kidney Provisional MRLs expire on 1. 1. 1996 50 μg/kg1 Liver, muscle, fat - 3.2.
Agents acting on the autonomic nervous system
- 3.2.1.
Anti-adrenergics
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions 3.2.1.1.
Carazolol
Carazolol All food producing species 30 μg/kg Liver Provisional MRLs expire on 1. 7. 1995 5 μg/kg Kidney, muscle, fat ANNEX IV
List of pharmacologically active substances for which no maximum levels can be fixed
- 1..
Nitrofurans, except furazolidone (see Annex III)
- 2..
Ronidazole
- 3..
Dapsone
- 4..
Chloramphenicol